[{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"JAPAN","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Istradefylline","moa":"Adenosine A2a receptor","graph1":"Neurology","graph2":"Phase III","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"10","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"JAPAN","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Istradefylline","moa":"Adenosine A2a receptor","graph1":"Neurology","graph2":"Phase III","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"10","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"JAPAN","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Istradefylline","moa":"Adenosine A2a receptor","graph1":"Neurology","graph2":"Phase III","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"10","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Hepatology (Liver, Pancreatic, Gall Bladder)","country":"JAPAN","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Istradefylline","moa":"Adenosine A2a receptor","graph1":"Hepatology (Liver, Pancreatic, Gall Bladder)","graph2":"Phase I","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Hepatology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"6","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"JAPAN","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Istradefylline","moa":"Adenosine A2a receptor","graph1":"Psychiatry\/Psychology","graph2":"Phase I","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"6","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"JAPAN","productType":"Antibody, Unconjugated","year":"2010","type":"Inapplicable","leadProduct":"Mogamulizumab","moa":"C-C chemokine receptor type 4","graph1":"Oncology","graph2":"Phase II","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"8","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"JAPAN","productType":"Antibody, Unconjugated","year":"2012","type":"Inapplicable","leadProduct":"Mogamulizumab","moa":"C-C chemokine receptor type 4","graph1":"Oncology","graph2":"Phase II","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"8","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Memorial Sloan Kettering Cancer Center","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Antibody, Unconjugated","year":"2014","type":"Inapplicable","leadProduct":"Mogamulizumab","moa":"C-C chemokine receptor type 4","graph1":"Oncology","graph2":"Phase I\/ Phase II","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"7","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Moffitt Cancer Center","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Antibody, Unconjugated","year":"2024","type":"Inapplicable","leadProduct":"Mogamulizumab","moa":"C-C chemokine receptor type 4","graph1":"Oncology","graph2":"Phase I","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"6","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Rare Diseases and Disorders","country":"JAPAN","productType":"Antibody, Unconjugated","year":"2012","type":"Inapplicable","leadProduct":"KRN23","moa":"Fibroblast growth factor 23","graph1":"Rare Diseases and Disorders","graph2":"Phase IV","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Rare Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"11","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Hakko Bio","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"U.S.A","productType":"Amino Acid","year":"2020","type":"Inapplicable","leadProduct":"Citrulline","moa":"G-protein coupled receptor GPCR33 (GPRC6A)","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"JAPAN","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"KW-2478","moa":"Heat shock protein 90 alpha (HSP90A)","graph1":"Oncology","graph2":"Phase I\/ Phase II","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"7","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Hakko Bio","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Peptide, Unconjugated","year":"2014","type":"Inapplicable","leadProduct":"Setria Glutathione","moa":"Immunostimulant","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Hakko Bio","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Peptide, Unconjugated","year":"2015","type":"Inapplicable","leadProduct":"Setria Glutathione","moa":"Immunostimulant","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"JAPAN","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"KW-2450","moa":"Insulin-like growth factor I receptor | Insulin receptor","graph1":"Oncology","graph2":"Phase I","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"6","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"University of Cincinnati","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Dietary Supplement","year":"2016","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ University of Cincinnati","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ University of Cincinnati"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Biofortis Clinical Research, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Dietary Supplement","year":"2017","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Biofortis Clinical Research, Inc.","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Biofortis Clinical Research, Inc."},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Oregon Health and Science University","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Dietary Supplement","year":"2018","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Oregon Health and Science University","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Oregon Health and Science University"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"JAPAN","productType":"Antibody, Unconjugated","year":"2011","type":"Inapplicable","leadProduct":"KHK2866","moa":"Proheparin-binding EGF-like growth factor","graph1":"Oncology","graph2":"Phase I","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"6","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"JAPAN","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"HMO","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Undisclosed"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Kirin","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"JAPAN","productType":"Undisclosed","year":"2014","type":"Inapplicable","leadProduct":"KHK6640","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase I","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"6","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Hakko Bio","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"Alanyl Glutamine","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Kyowa Hakko Bio","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"UNITED KINGDOM","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Kyowa Hakko Bio","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Kyowa Hakko Bio"}]
Find Clinical Drug Pipeline Developments & Deals by Kyowa Hakko Bio
Filters
×
FILTER:
Company Name
Year
DEALS // DEV.
Country
Sponsor
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Reset All
